ALNY Alnylam Pharmaceuticals Inc

$454.38

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.

Website: https://www.alnylam.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1178670
Address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US
Valuation
Market Cap
$30.36B
P/E Ratio
nan
PEG Ratio
-0.49
Price to Book
452.51
Performance
EPS
$-2.18
Dividend Yield
—
Profit Margin
-12.40%
ROE
-1501.00%
Technicals
50D MA
$251.88
200D MA
$258.96
52W High
$304.39
52W Low
$141.98
Fundamentals
Shares Outstanding
129M
Target Price
$315.43
Beta
0.30

ALNY EPS Estimates vs Actual

● Estimated
● Actual

ALNY News & Sentiment

Aug 22, 2025 • Benzinga NEUTRAL
A Closer Look at Alnylam Pharmaceuticals's Options Market Dynamics - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Financial giants have made a conspicuous bullish move on Alnylam Pharmaceuticals. Our analysis of options history for Alnylam Pharmaceuticals ALNY revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 30% showed bearish tendencies.
Aug 13, 2025 • Benzinga SOMEWHAT-BULLISH
How Is The Market Feeling About Alnylam Pharmaceuticals? - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Alnylam Pharmaceuticals's ALNY short percent of float has fallen 4.34% since its last report. The company recently reported that it has 3.24 million shares sold short, which is 3.31% of all regular shares that are available for trading.
Aug 13, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Alnylam Pharmaceuticals ALNY has outperformed the market over the past 10 years by 2.77% on an annualized basis producing an average annual return of 14.61%. Currently, Alnylam Pharmaceuticals has a market capitalization of $56.09 billion.
Aug 11, 2025 • Benzinga NEUTRAL
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors - KalVista Pharmaceuticals ( NASDAQ:KALV ) , Metagenomi ( NASDAQ:MGX )
EMERYVILLE, Calif., Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Metagenomi, Inc. MGX ( the "Company" ) , a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the appointment of Laurence Reid, PhD, to ...
Aug 11, 2025 • Zacks Commentary BULLISH
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Aug 05, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should Invesco NASDAQ Next Gen 100 ETF ( QQQJ ) Be on Your Investing Radar?
Style Box ETF report for ...
Sentiment Snapshot

Average Sentiment Score:

0.286
50 articles with scored sentiment

Overall Sentiment:

Bullish

ALNY Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.36 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: 97.3%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $0.06
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: 142.5%
Oct 31, 2024
Sep 30, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.87
  • Estimate: $-0.93
  • Whisper: —
  • Surprise %: 6.5%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.95 Surprise
  • Reported EPS: $-0.13
  • Estimate: $-1.08
  • Whisper: —
  • Surprise %: 88.0%
May 02, 2024
Mar 31, 2024 (Pre market)
0.66 Surprise
  • Reported EPS: $-0.52
  • Estimate: $-1.18
  • Whisper: —
  • Surprise %: 55.9%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.22 Surprise
  • Reported EPS: $-1.10
  • Estimate: $-1.32
  • Whisper: —
  • Surprise %: 16.7%
Nov 02, 2023
Sep 30, 2023 (Pre market)
2.49 Surprise
  • Reported EPS: $1.15
  • Estimate: $-1.34
  • Whisper: —
  • Surprise %: 185.8%
Aug 03, 2023
Jun 30, 2023 (Pre market)
-0.84 Surprise
  • Reported EPS: $-2.21
  • Estimate: $-1.37
  • Whisper: —
  • Surprise %: -61.3%
May 04, 2023
Mar 31, 2023 (Pre market)
0.37 Surprise
  • Reported EPS: $-1.40
  • Estimate: $-1.77
  • Whisper: —
  • Surprise %: 20.9%

Financials